Form D · Other Health Care
IpiNovyx Bio, Inc.
West Nyack, NY · CIK 0001887961
Offering snapshot reported Oct 14, 2021 · SEC filing
- Reported sold
- $7M Offering amount: $10M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2021 | Initial | $7,000,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-416892
Source: Form D, filed Oct 14, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Appel | Director, Executive |
| Lutz Giebel | Director |
| James Graham | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11 Aberdeen Drive
West Nyack, NY, 10994
West Nyack, NY, 10994